Immunosuppressive Treatment for Proliferative Lupus Nephritis: Summary of a Cochrane Review  David J. Tunnicliffe, Suetonia C. Palmer  American Journal of Kidney Diseases  Volume 72, Issue 5, Pages 756-757 (November 2018) DOI: 10.1053/j.ajkd.2018.07.008 Copyright © 2018 Terms and Conditions

Figure 1 Forest plot of mycophenolate mofetil (MMF) versus intravenous (IV) cyclophosphamide (CPA) complete renal remission. Abbreviations: CI, confidence interval; M-H, Mantel-Haenszel. Adapted from Tunnicliffe et al5 with permission of the copyright holder; original image © 2018 The Cochrane Collaboration and was published by John Wiley & Sons, Ltd. American Journal of Kidney Diseases 2018 72, 756-757DOI: (10.1053/j.ajkd.2018.07.008) Copyright © 2018 Terms and Conditions